Literature DB >> 35601180

Exosome-mediated aptamer S58 reduces fibrosis in a rat glaucoma filtration surgery model.

Qian-Yi Lin1, Xiang-Ji Li1, Yu Leng1, Xiao-Min Zhu1, Min Tang1, Yi Lin1, Wang-Du Luo1, Bing-Cai Jiang1, Xia Chen2, Lin Xie1.   

Abstract

AIM: To confirm whether exosome-mediated delivery of aptamer S58 (Exo-S58) has a better antifibrotic effect than naked S58 in human conjunctival fibroblasts (HConFs) and a rat glaucoma filtration surgery (GFS) model.
METHODS: To enhance the effective reaction time of aptamer S58 in vivo, we loaded aptamer S58 into exosomes derived from HEK293T cells by PEI transfection to determine the effect of Exo-S58 in HConFs and a rat GFS model.
RESULTS: Exo-S58 can significantly reduce cell proliferation, migration and fibrosis in TGF-β2-induced HConFs. In an in vivo experiment, Exo-S58 treatment prolonged filtering bleb retention and reduced fibrosis compared with naked S58 treatment in GFS rats.
CONCLUSION: The exosomes are safe and valid carriers to deliver aptamers. Furthermore, Exo-S58 exhibited superior antifibrotic effect than naked S58 both in HConFs cells and rat GFS models. International Journal of Ophthalmology Press.

Entities:  

Keywords:  anti-fibrosis; aptamer; drug delivery; exosomes; glaucoma surgery; nanomedicine; transforming growth factor-beta

Year:  2022        PMID: 35601180      PMCID: PMC9091888          DOI: 10.18240/ijo.2022.05.02

Source DB:  PubMed          Journal:  Int J Ophthalmol        ISSN: 2222-3959            Impact factor:   1.645


  65 in total

Review 1.  Modulation of Fibroblasts in Conjunctival Wound Healing.

Authors:  Mark Zada; Ushasree Pattamatta; Andrew White
Journal:  Ophthalmology       Date:  2017-11-01       Impact factor: 12.079

2.  Delivery of siRNA to the mouse brain by systemic injection of targeted exosomes.

Authors:  Lydia Alvarez-Erviti; Yiqi Seow; Haifang Yin; Corinne Betts; Samira Lakhal; Matthew J A Wood
Journal:  Nat Biotechnol       Date:  2011-03-20       Impact factor: 54.908

Review 3.  Design and development of polymers for gene delivery.

Authors:  Daniel W Pack; Allan S Hoffman; Suzie Pun; Patrick S Stayton
Journal:  Nat Rev Drug Discov       Date:  2005-07       Impact factor: 84.694

Review 4.  Glaucoma.

Authors:  Jost B Jonas; Tin Aung; Rupert R Bourne; Alain M Bron; Robert Ritch; Songhomitra Panda-Jonas
Journal:  Lancet       Date:  2017-05-31       Impact factor: 79.321

Review 5.  Current trends in the use of liposomes for tumor targeting.

Authors:  Pranali P Deshpande; Swati Biswas; Vladimir P Torchilin
Journal:  Nanomedicine (Lond)       Date:  2013-09       Impact factor: 5.307

Review 6.  Global causes of blindness and distance vision impairment 1990-2020: a systematic review and meta-analysis.

Authors:  Seth R Flaxman; Rupert R A Bourne; Serge Resnikoff; Peter Ackland; Tasanee Braithwaite; Maria V Cicinelli; Aditi Das; Jost B Jonas; Jill Keeffe; John H Kempen; Janet Leasher; Hans Limburg; Kovin Naidoo; Konrad Pesudovs; Alex Silvester; Gretchen A Stevens; Nina Tahhan; Tien Y Wong; Hugh R Taylor
Journal:  Lancet Glob Health       Date:  2017-10-11       Impact factor: 26.763

7.  Taxol-Loaded MSC-Derived Exosomes Provide a Therapeutic Vehicle to Target Metastatic Breast Cancer and Other Carcinoma Cells.

Authors:  Catharina Melzer; Vanessa Rehn; Yuanyuan Yang; Heike Bähre; Juliane von der Ohe; Ralf Hass
Journal:  Cancers (Basel)       Date:  2019-06-09       Impact factor: 6.639

Review 8.  Glaucoma history and risk factors.

Authors:  Charles W McMonnies
Journal:  J Optom       Date:  2016-03-23

9.  Macrophage-derived exosomes attenuate fibrosis in airway epithelial cells through delivery of antifibrotic miR-142-3p.

Authors:  Ingrid Struman; Makon-Sébastien Njock; Julien Guiot; Maureen Cambier; Amandine Boeckx; Monique Henket; Olivier Nivelles; Fanny Gester; Edouard Louis; Michel Malaise; Franck Dequiedt; Renaud Louis
Journal:  Thorax       Date:  2020-08-05       Impact factor: 9.139

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.